跳至主要内容
临床试验/CTIS2023-506550-20-00
CTIS2023-506550-20-00招募中1 期

FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: A pilot study for a randomized clinical trial (MONITOR-PILOT)

Odense University Hospital0 个研究点目标入组 30 人开始时间: 2023年12月8日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Women and men aged=18 years, Diagnosis of distant relapsed MBC (biopsy-verified) or de novo breast cancer (biopsy verification of primary tumor and disseminated disease at baseline scan), Considered eligible for first-line systemic treatment, Considered eligible for continuous treatment monitoring by scans, Signed informed consent, Ability to read and understand Danish language

排除标准

  • Pregnant or lactating women, Ongoing oncological treatment for another cancer, Exclusively brain metastasis, Allergy to FDG

研究者

相似试验